ccr-covid19symposium (Overview)

NIH/FDA COVID-19 Research Workshop


December 15 - 16, 2022
Virtual Event

Overview

Welcome to the 2022 COVID-19 Scientific Interest Group Symposium registration site.

The last two and a half years have brought unprecedented changes to the world with the COVID-19 pandemic. In response to this challenge, the scientific community has mobilized on many fronts with advances in vaccines, diagnostics, treatments, pathology, immunology, virology, structural biology, cell biology, epidemiology and many other areas. However, many challenges still remain, particularly in the areas of long-term pathology, treatments, viral variants, and the development of broadly protective vaccines. To help facilitate interactions and highlight work from NIH/FDA investigators, the NIH/FDA COVID-19 scientific interest group is hosting our second virtual workshop for NIH/FDA staff on Thursday, December 15, and Friday, December 16, 2022, from 11:00 a.m. to 5:00 p.m. We look forward to your active participation to make this workshop a success during this challenging time.

Registration for the 2022 NIH/FDA COVID-19 Symposium is NOW OPEN.
 

Here are some essential things to know about the Workshop:

  • The symposium will consist of a mixture of talks and flash talks chosen from the abstracts. While you do not need to submit an abstract to attend, we encourage abstracts to be submitted for all stages of research.
  • Abstracts should be no longer than 300 words. Keep in mind that the abstract that is submitted in your registration is the final version. Edits or changes in your abstract cannot be accepted after you have completed your registration unless you contact the organizers. Use only Roman characters. Please proofread carefully and make sure you have checked with your PI (if needed) before you submit your abstract. Abstracts may be withdrawn BEFORE October 21, 2020 by contacting the organizers.
  • Abstract submission will be closed on October 21, 2022. We have received a lot of interest in this symposium and we expect registration to fill up rapidly. Although there is no physical space limitation, registration will still be closed when we reach capacity to hold the virtual workshop program, so please register as soon as possible.
  • Official Acceptance will follow in a separate email and will be on a strict first-come, first-serve basis and favor those with science to share (i.e. with an abstract). Please, register EARLY. Only registered individuals will receive an electronic list of the abstracts and an invitation to access the virtual workshop.

We expect to have a full and exciting agenda of cutting-edge talks and flash talk sessions. In lieu of posters, presenters will have the opportunity to give 3-5 minute "flash" talks.

The virtual workshop will be limited to members of the NIH and FDA communities, so your active participation is highly encouraged. We hope that this will be a major opportunity for researchers to share their most exciting COVID-19 research with the NIH/FDA community.

General Information

For conference related questions, please contact: Pam SchwartzbergNihal Altan-Bonnet, or Alex Compton.